GlaxoSmithKline PLC (NYSE:GSK)

Delayed Data
As of Jul 22
 +0.17 / +0.42%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 41.30, with a high estimate of 48.79 and a low estimate of 35.37. The median estimate represents a +0.42% increase from the last price of 41.13.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.90%
Growthannually -6.88%


Growthquarterly -4.26%
Growthannually 3.53%
Key to the earnings and sales forecast charts.